{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:36:43Z","timestamp":1793317003753,"version":"4.5.0"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":85,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>During pregnancy and lactation, the maternal skeleton undergoes significant bone loss through increased resorption to provide the necessary calcium supply to the developing fetus and suckling neonate. This period of skeletal vulnerability has not been clearly associated with increased maternal fracture risk, but these physiological conditions can exacerbate an underlying metabolic bone condition like osteogenesis imperfecta. Although bisphosphonates (BPs) are commonly used in postmenopausal women, there are cases where premenopausal women taking BPs become pregnant. Given BPs\u2019 long half-life, there is a need to establish how BPs affect the maternal skeleton during periods of demanding metabolic bone changes that are critical for the skeletal development of their offspring. In the present study, pamidronate- (PAM-) amplified pregnancy-induced bone mass gains and lactation-induced bone loss were prevented. This preservation of bone mass was less robust when PAM was administered at late stages of lactation compared with early pregnancy and first day of lactation. Pregnancy-induced osteocyte osteolysis was also observed and was unaffected with PAM treatment. No negative skeletal effects were observed in offspring from PAM-treated dams despite lactation-induced bone loss prevention. These findings provide important insight into (1) a treatment window for when PAM is most effective in preserving maternal bone mass, and (2) the maternal changes in bone metabolism that maintain calcium homeostasis crucial for fetal and neonatal bone development. \u00a9 2019 American Society for Bone and Mineral Research<\/jats:p>","DOI":"10.1002\/jbmr.3831","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T14:02:57Z","timestamp":1563285777000},"page":"2061-2074","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta"],"prefix":"10.1093","volume":"34","author":[{"given":"Diana","family":"Olvera","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering University of Michigan Ann Arbor MI USA"},{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Stolzenfeld","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Nolan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S","family":"Caird","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M","family":"Kozloff","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering University of Michigan Ann Arbor MI USA"},{"name":"Department of Orthopaedic Surgery University of Michigan Ann Arbor MI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0001","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/EJE-14-0424","article-title":"Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture","volume":"172","author":"Sanz-Salvador","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2024021014460745200_jbmr3831-bib-0002","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/jp.2016.111","article-title":"Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study","volume":"36","author":"Ruiter-Ligeti","year":"2016","journal-title":"J Perinatol."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0003","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00404-016-4012-2","article-title":"Management of osteogenesis imperfecta type I in pregnancy; a review of literature applied to clinical practice","volume":"293","author":"Cozzolino","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0004","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/gim.2015.131","article-title":"Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta","volume":"18","author":"Bellur","year":"2016","journal-title":"Genet Med."},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0005","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00000539-200205000-00049","article-title":"Pregnancy complicated by severe osteogenesis imperfecta: a report of two cases","volume":"94","author":"Vogel","year":"2002","journal-title":"Anesth Analg."},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/01443610120113328","article-title":"Musculo-skeletal problems associated with pregnancy in women with osteogenesis imperfecta","volume":"22","author":"McAllion","year":"2002","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0007","first-page":"66","article-title":"Osteogenesis imperfecta: mode of delivery and neonatal outcome","volume":"97","author":"Cubert","year":"2001","journal-title":"Obstet Gynecol."},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0008","first-page":"168","article-title":"Management of pregnancy in osteogenesis imperfecta: new perspectives","volume":"45","author":"Roberts","year":"1975","journal-title":"Obstet Gynecol."},{"key":"2024021014460745200_jbmr3831-bib-0009","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1590\/S0004-27302010000200017","article-title":"Bisphosphonates in the treatment of metabolic bone diseases","volume":"54","author":"Arantes","year":"2010","journal-title":"Arquivos Brasileiros de Endocrinologia & Metabologia"},{"issue":"9","key":"2024021014460745200_jbmr3831-bib-0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2024021014460745200_jbmr3831-bib-0012","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","article-title":"A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta","volume":"25","author":"Bishop","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0014","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2410","article-title":"Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials","volume":"30","author":"Hald","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0017","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/WHE.13.73","article-title":"A review of osteoporosis management in younger premenopausal women","volume":"10","author":"McLendon","year":"2014","journal-title":"Women's Health"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/157488610790936178","article-title":"The safety of bisphosphonate use in pre-menopausal women on corticosteroids","volume":"5","author":"McNicholl","year":"2010","journal-title":"Curr Drug Saf"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2010.02.018","article-title":"Should bisphosphonates be used in premenopausal women?","volume":"66","author":"Cohen","year":"2010","journal-title":"Maturitas."},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/j.1552-4604.1993.tb03946.x","article-title":"Adverse effects of drugs and chemicals in breast milk on the nursing infant","volume":"33","author":"Kacew","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"16","key":"2024021014460745200_jbmr3831-bib-0022","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","article-title":"Drugs in pregnancy","volume":"338","author":"Koren","year":"1998","journal-title":"N Engl J Med"},{"key":"2024021014460745200_jbmr3831-bib-0023","year":"2001"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0024","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2125.2009.03366.x","article-title":"Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine","volume":"67","author":"Bartu","year":"2009","journal-title":"Brit J Clin Pharmacol"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0025","first-page":"23","article-title":"Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options","volume":"99","author":"De Nijs","year":"2008","journal-title":"Minerva Med."},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0026","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2036.2008.03899.x","article-title":"Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis","volume":"29","author":"Kitazaki","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00774-011-0334-0","article-title":"Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures","volume":"30","author":"Choe","year":"2012","journal-title":"J Bone Miner Metabol"},{"key":"2024021014460745200_jbmr3831-bib-0028","first-page":"82","article-title":"Osteogenesis imperfecta presenting with fractures in pregnancy or lactation period: report of three cases","volume":"7","author":"Tanr\u0131kulu","year":"2015","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0029","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/pds.1538","article-title":"Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population","volume":"17","author":"Yang","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H","article-title":"Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats","volume":"60","author":"Patlas","year":"1999","journal-title":"Teratology."},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0031","first-page":"654","article-title":"Reproduction toxicity studies with pamidronate","volume":"42","author":"Graepel","year":"1992","journal-title":"Arzneimittelforschung."},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0032","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/taap.1993.1148","article-title":"Effects of the bisphosphonate, alendronate, on parturition in the rat","volume":"121","author":"Minsker","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Suppl 1","key":"2024021014460745200_jbmr3831-bib-0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.20.SupplementI_1","article-title":"Intravenous reproductive and developmental toxicity studies of cimadronate (YM175), a novel bisphosphonate, in rats and rabbits","volume":"20","author":"Okazaki","year":"1995","journal-title":"J Toxicol Sci"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0034","first-page":"569","article-title":"Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resportion","volume":"83","author":"Yarrington","year":"1976","journal-title":"Am J Pathol"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF02555983","article-title":"Inhibition of bone mineral loss during lactation by Cl2MBP","volume":"47","author":"Brommage","year":"1990","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"2024021014460745200_jbmr3831-bib-0036","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.49.11.955-a","article-title":"Antenatal administration of aminopropylidene diphosphonate","volume":"49","author":"Dunlop","year":"1990","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0037","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0936-6555(05)80667-3","article-title":"Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate","volume":"8","author":"Illidge","year":"1996","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0038","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00198-009-0983-1","article-title":"Maternal and fetal outcome after long-term bisphosphonate exposure before conception","volume":"21","author":"Hassen-Zrour","year":"2010","journal-title":"Osteoporos Int."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0039","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2005-2548","article-title":"Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases","volume":"91","author":"Chan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024021014460745200_jbmr3831-bib-0040","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00198-009-1138-0","article-title":"Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health","volume":"21","author":"Mastaglia","year":"2010","journal-title":"Osteoporos Int."},{"issue":"10","key":"2024021014460745200_jbmr3831-bib-0041","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1359\/jbmr.2000.15.10.2052","article-title":"Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding","volume":"15","author":"Siminoski","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024021014460745200_jbmr3831-bib-0042","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1359\/JBMR.040711","article-title":"Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bdra.10016","article-title":"No effects of bisphosphonates on the human fetus","volume":"67","author":"Rutgers-Verhage","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0044","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bone.2008.11.001","article-title":"Pregnancy outcome following in utero exposure to bisphosphonates","volume":"44","author":"Levy","year":"2009","journal-title":"Bone."},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.reprotox.2006.05.009","article-title":"The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment","volume":"22","author":"Ornoy","year":"2006","journal-title":"Reproduct Toxicol"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0046","first-page":"344","article-title":"Maternal and fetal outcome of pamidronate treatment before conception: a case report","volume":"25","author":"Cabar","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"53","key":"2024021014460745200_jbmr3831-bib-0047","doi-asserted-by":"crossref","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","article-title":"Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice","volume":"274","author":"Forlino","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0048","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1359\/JBMR.040111","article-title":"Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength","volume":"19","author":"Kozloff","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024021014460745200_jbmr3831-bib-0049","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","article-title":"Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors","volume":"23","author":"Uveges","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0050","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of Brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation","volume":"24","author":"Uveges","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0051","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbmr.1717","article-title":"Sclerostin antibody improves skeletal parameters in a Brtl\/+\u2009mouse model of osteogenesis imperfecta","volume":"28","author":"Sinder","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"8","key":"2024021014460745200_jbmr3831-bib-0052","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00198-014-2737-y","article-title":"Adult Brtl\/+\u2009mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength","volume":"25","author":"Sinder","year":"2014","journal-title":"Osteoporos Int."},{"key":"2024021014460745200_jbmr3831-bib-0053","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.10.012","article-title":"Rapidly growing Brtl\/+\u2009mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment","volume":"71","author":"Sinder","year":"2015","journal-title":"Bone."},{"key":"2024021014460745200_jbmr3831-bib-0054","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bone.2016.09.013","article-title":"Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl\/+\u2009osteogenesis imperfecta model","volume":"93","author":"Perosky","year":"2016","journal-title":"Bone."},{"issue":"7","key":"2024021014460745200_jbmr3831-bib-0055","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/jbmr.3421","article-title":"Low dose of bisphosphonate enhances sclerostin antibody-induced trabecular bone mass gains in Brtl\/+\u2009osteogenesis imperfecta mouse model","volume":"33","author":"Olvera","year":"2018","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0056","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1679\/aohc.66.123","article-title":"Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants","volume":"66","author":"Kawamoto","year":"2003","journal-title":"Arch Histol Cytol"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0057","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jbmr.1503","article-title":"Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice","volume":"27","author":"Liu","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2024021014460745200_jbmr3831-bib-0058","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0059","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bone.2013.01.025","article-title":"Osteocytes remove and replace perilacunar mineral during reproductive cycles","volume":"54","author":"Wysolmerski","year":"2013","journal-title":"Bone."},{"key":"2024021014460745200_jbmr3831-bib-0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/bonekey.2012.229","article-title":"Osteocytic osteolysis: time for a second look?","volume":"1","author":"Wysolmerski","year":"2012","journal-title":"Bonekey Rep."},{"issue":"12","key":"2024021014460745200_jbmr3831-bib-0061","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","article-title":"Does treatment with bisphosphonates endanger the human pregnancy?","volume":"30","author":"Djokanovic","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0062","doi-asserted-by":"crossref","first-page":"280","DOI":"10.14310\/horm.2002.1319","article-title":"The use of bisphosphonates in women prior to or during pregnancy and lactation","volume":"10","author":"Stathopoulos","year":"2011","journal-title":"Hormones (Athens)"},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0063","first-page":"832","article-title":"Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation","volume":"18","author":"Kovacs","year":"1997","journal-title":"Endocr Rev."},{"issue":"8","key":"2024021014460745200_jbmr3831-bib-0064","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/jbmr.5650110803","article-title":"Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis","volume":"11","author":"Sowers","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0065","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jbmr.339","article-title":"Skeletal recovery after weaning does not require PTHrP","volume":"26","author":"Kirby","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014460745200_jbmr3831-bib-0066","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bone.2016.03.012","article-title":"Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice","volume":"87","author":"Wendelboe","year":"2016","journal-title":"Bone."},{"issue":"11","key":"2024021014460745200_jbmr3831-bib-0067","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00198-009-1138-0","article-title":"Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health","volume":"21","author":"Mastaglia","year":"2010","journal-title":"Osteoporos Int."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0068","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S8756-3282(99)00228-8","article-title":"Bone mass changes during pregnancy and lactation in the rat","volume":"25","author":"Zeni","year":"1999","journal-title":"Bone."},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0069","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0021859600040491","article-title":"Studies of the skeleton of the sheep I. The effect of different levels of dietary calcium during pregnancy and lactation on individual bones","volume":"46","author":"Benzie","year":"2009","journal-title":"J Agricult Sci"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/8756-3282(86)90209-7","article-title":"Changes in bone mineral and bone formation rates during pregnancy and lactation in rats","volume":"7","author":"Miller","year":"1986","journal-title":"Bone."},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0071","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02738961","article-title":"Endochondral bone growth during early pregnancy compared with pseudopregnancy in rats","volume":"6","author":"Bowman","year":"1997","journal-title":"Endocrine."},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0072","first-page":"347","article-title":"Skeletal adaptations during mammalian reproduction","volume":"1","author":"Bowman","year":"2001","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0073","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1095\/biolreprod61.6.1439","article-title":"Increased intracortical bone remodeling during lactation in beagle dogs","volume":"61","author":"Vajda","year":"1999","journal-title":"Biol Reprod."},{"issue":"1 Pt 1","key":"2024021014460745200_jbmr3831-bib-0074","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9378(98)70649-0","article-title":"Bone structural and metabolic changes at the end of pregnancy and lactation in rats","volume":"178","author":"Tojo","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2024021014460745200_jbmr3831-bib-0075","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1210\/en.2010-0566","article-title":"Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton","volume":"151","author":"Ardeshirpour","year":"2010","journal-title":"Endocrinology."},{"issue":"11","key":"2024021014460745200_jbmr3831-bib-0076","doi-asserted-by":"crossref","DOI":"10.1115\/1.4038110","article-title":"Reproduction differentially affects trabecular bone depending on its mechanical versus metabolic role","volume":"139","author":"de Bakker","year":"2017","journal-title":"J Biomech Eng"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0077","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00223-017-0270-7","article-title":"Bone matrix maturation in a rat model of intra-cortical bone remodeling","volume":"101","author":"Ross","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"2024021014460745200_jbmr3831-bib-0078","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-989-5_1","article-title":"Overview of skeletal development","volume":"1130","author":"Kobayashi","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0079","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/jcem-33-4-661","article-title":"Calcium metabolism in normal human pregnancy","volume":"33","author":"Heaney","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024021014460745200_jbmr3831-bib-0080","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1359\/jbmr.2002.17.11.1954","article-title":"Greatly increased cancellous bone formation with rapid improvements in bone structure in the rat maternal skeleton after lactation","volume":"17","author":"Bowman","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0081","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ar.20403","article-title":"Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation","volume":"290","author":"Miller","year":"2007","journal-title":"Anat Rec (Hoboken)"},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0082","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2005.04.041","article-title":"High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse","volume":"37","author":"Yang","year":"2005","journal-title":"Bone."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0083","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0084","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/en.2011-1439","article-title":"Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice","volume":"153","author":"Kuroshima","year":"2012","journal-title":"Endocrinology."},{"issue":"3","key":"2024021014460745200_jbmr3831-bib-0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1359\/jbmr.2003.18.3.482","article-title":"Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival","volume":"18","author":"Croucher","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0086","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/aja.1001780410","article-title":"Annual skeletal changes in the little brown bat, Myotis lucifugus lucifugus, with particular reference to pregnancy and lactation","volume":"178","author":"Kwiecinski","year":"1987","journal-title":"Am J Anat"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0087","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02012771","article-title":"Calcium deficiency, pregnancy, and lactation in rats","volume":"23","author":"Rasmussen","year":"1977","journal-title":"Calcif Tissue Res"},{"issue":"4","key":"2024021014460745200_jbmr3831-bib-0088","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.3044","article-title":"Lactation-induced changes in the volume of osteocyte lacunar-canalicular space alter mechanical properties in cortical bone tissue","volume":"32","author":"Kaya","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2024021014460745200_jbmr3831-bib-0089","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1210\/en.2015-1345","article-title":"A role for the calcitonin receptor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis","volume":"156","author":"Clarke","year":"2015","journal-title":"Endocrinology."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00774-004-0519-x","article-title":"Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered","volume":"22","author":"Tazawa","year":"2004","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2024021014460745200_jbmr3831-bib-0091","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery","volume":"96","author":"Kovacs","year":"2016;","journal-title":"Physiol Rev."},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0092","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ar.1091200104","article-title":"Equivalent ages in mouse and human embryos","volume":"120","author":"Otis","year":"1954","journal-title":"Anatom Rec"},{"issue":"1","key":"2024021014460745200_jbmr3831-bib-0093","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jez.1402490109","article-title":"A staging system for mouse limb development","volume":"249","author":"Wanek","year":"1989","journal-title":"J Exp Zool."},{"key":"2024021014460745200_jbmr3831-bib-0094","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"issue":"6","key":"2024021014460745200_jbmr3831-bib-0095","first-page":"624","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Preven Med."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3831","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.3831","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.3831","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/11\/2061\/56655030\/jbmr3831.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/11\/2061\/56655030\/jbmr3831.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:04:37Z","timestamp":1710342277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/34\/11\/2061-2074\/7605916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,7,16]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3831","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,1]]},"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"2018-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}